Results 221 to 230 of about 14,906 (242)

Study on the mechanism of BGN in progression and metastasis of ccRCC. [PDF]

BMC Med Genomics
Xia H, He T, Li X, Zhao K, Zhang Z, Zhu G, Yang H, Yan X, Wang Q, Li Z, Jiang Z, Wang K, Yin X.   +12 more
europepmc   +1 more source

Cardiac implications of chicken wooden breast myopathy. [PDF]

Front Physiol
Støle TP, Romaine A, Kleiberg T, Høst V, Lunde M, Hasic A, Lintvedt TA, Sanden KW, Kolset SO, Wold JP, Pisconti A, Rønning SB, Carlson CR, Pedersen ME.   +13 more
europepmc   +1 more source

Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling. [PDF]

Acta Neuropathol Commun
Okonechnikov K, Ghasemi DR, Schrimpf D, Tonn S, Mynarek M, Koster J, Milde T, Zheng T, Sievers P, Sahm F, Jones DTW, von Deimling A, Pfister SM, Kool M, Pajtler KW, Korshunov A.   +15 more
europepmc   +1 more source

Morphological determinants of glycosylation efficiency in Golgi cisternae

Revell CK, Stevenson NL, Lowe M, Jensen OE.   +3 more
europepmc   +1 more source

Golgins support extracellular matrix secretion by collectively maintaining the Golgi structure-function relationship

Thompson G, Hoyle A, Lewis PA, Esther Prada-Sanchez M, Swift J, Heesom K, Lowe M, Stephens D, Stevenson N.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Biglycan: A regulator of hepatorenal inflammation and autophagy

Matrix Biology, 2021
Soluble biglycan, a small leucine-rich proteoglycan, plays a significant role in several pathologies as it has emerged as an extracellular matrix-derived danger-associated molecular pattern. Biglycan is released from the extracellular matrix in response to tissue injury and, as a canonical danger signal, interacts with innate immune receptors, Toll ...
Martin Sebastian McCoy, Valentina Diehl, Jonel Trebicka, Malgorzata Wygrecka, Liliana Schaefer   +4 more
openaire   +2 more sources

Hyperelongated biglycan: the surreptitious initiator of atherosclerosis

Current Opinion in Lipidology, 2008
To outline a role for the dermatan sulfate proteoglycan biglycan and specifically its growth factor modified form having elongated glycosaminoglycan chains as being a primary initiator of atherosclerosis.Antiatherosclerotic therapies have mostly targeted epidemiologically identified, experimentally confirmed risk factors. The efficacy of such therapies
Little, Peter J., Osman, Narin, O'Brien, Kevin D.   +2 more
openaire   +3 more sources

Hematopoietic Activity Associated with Biglycan-like Proteoglycan

Biochemical and Biophysical Research Communications, 1993
One of the monocytic cell colony stimulating factors produced by thymic myoid cells, a 100 kDa factor, was purified by reversed phase HPLC and found to be homologous to the secreted form of proteoglycan 1 (biglycan) core protein. This biglycan associated colony stimulating factor did not carry an immunological motif of macrophage colony stimulating ...
I, Kamo, A, Kikuchi, I, Nonaka, E, Yamada, J, Kondo   +4 more
openaire   +2 more sources

Regulation, Regulatory Activities, and Function of Biglycan

Critical Reviews™ in Eukaryotic Gene Expression, 2004
Biglycan is a member of the small leucine repeat proteoglycan family (SLRP). The biglycan gene is located on the X chromosome. Based on the amino acid sequence, the protein core of biglycan can be divided into six distinct domains: (1) a signal sequence, (2) a propeptide region, (3) a N-terminal glycosaminoglycan attachment region, (4) a cysteine loop,
Sunil, Wadhwa, Mildred C, Embree, Yanming, Bi, Marian F, Young   +3 more
openaire   +2 more sources